Measurements of free and total PSA, tissue polypeptide-specific antigen (TPS), and CYFRA 21-1 in prostate cancer patients under intermittent androgen suppression therapy
- 8 September 1999
- journal article
- Published by Wiley in The Prostate
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- INTERPRETATION OF FREE PROSTATE SPECIFIC ANTIGEN CLINICAL RESEARCH STUDIES FOR THE DETECTION OF PROSTATE CANCERJournal of Urology, 1998
- Evolving strategies of cytotoxic chemotherapy for advanced prostate cancerEuropean Journal Of Cancer, 1997
- Androgens and prostate cancer: Biology, pathology and hormonal therapyEuropean Journal Of Cancer, 1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: A pilot studyUrology, 1996
- EDITORIAL COMMENTJournal of Urology, 1996
- Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigenCancer, 1993
- Cytotoxic chemotherapy for advanced hormone-resistant prostate cancerCancer, 1993
- Prostate specific antigen predominantly forms a complex with alpha1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serumCancer, 1992
- The Clinical Usefulness of Serum Prostate Specific Antigen After Hormonal Therapy of Metastatic Prostate CancerJournal of Urology, 1992